Adela
adelabio.comLocations
Toronto, ON, Canada · North York, Toronto, ON, Canada · Foster City, CA, USA
industry
Biotechnology
Size
51-200 employees
Stage
Series A
founded in
2020
Adela’s mission is to develop innovative and accessible technologies that harness biology and change the way we diagnose and treat disease. Adela’s genome-wide methylation enrichment technology was originally developed by Chief Scientific Officer Dr. Daniel de Carvalho, PhD, at University Health Network’s Princess Margaret Cancer Centre. Adela is initially planning to develop the technology for use across the entire cancer continuum—for detection, diagnosis, and management of disease.
Something looks off?Open jobs at Adela
On-site & Remote
Job function
Seniority
Salary